JPRN-UMIN000005668已完成未知
A randomized phase II trial to investigate optimal duration (4 month versus 6 month) of preoperative endocrine therapy - PTEX46 Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) History of chemotherapy or endocrine therapy for breast cancer. 2) Receiving any drugs that may affect the sex hormone status.
研究者
相似试验
招募中
2 期
A randomized phase II study investigating an optimal dosing regimen of TS-1 plus CDDP plus Trastuzumab combination therapy for HER2-positive unresectable and/or recurrent gastric cancernresectable and/or recurrent gastric cancerJPRN-UMIN000008254Juntendo University School of Medicine Department of Gastroenterology40
进行中（未招募）
1 期
A study to optimize immunotherapy in head and neck cancerrecurrent or metastatic squamous cell carcinoma of the head and neck (R/M-SCCHN) progressing after prior platinum-based therapy (radiochemo-therapy or systemic chemotherapy)MedDRA version: 20.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10071540Term: Head and neck cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003349-14-DEAIO-Studien-gGmbH280
进行中（未招募）
1 期
ocally Advanced or Metastatic Hepatocellular Carcinoma (HCC): Evaluation of the Optimized Dose, Safety, and Efficacy of Livmoniplimab in Combination with BudigalimabHepatocellular CarcinomaCTIS2022-502948-13-00Abbvie Deutschland GmbH & Co. KG120
已完成
2 期
A randomized phase 2 trial which investigate the most effective administration method of antithrombin (AT) products in patients with disseminated intravascular coagulation (DIC) associated with sepsis during treatment for advanced pancreatic and biliary cancer.advanced hepatobiliary and pancreatic cancer patientsJPRN-UMIN000015105Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology40
已完成
2 期
Randomized phase II trial to evaluate the effectiveness of azacitidine for low risk MDS.lower risk myelodysplastic syndromeJPRN-UMIN000010855ational Research Group on Idiopathic Bone Marrow Failure Syndromes100